| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | Chief Development Officer | 10% Owner
3 companies
Matt Davidson is 10% Owner at VRCA and has filed Form 4s across 3 companies. Matt Davidson's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $11.2M at current prices.
The biggest single holding is VRCA (~$8.4M) as 10% Owner. The VRCA filings lean toward selling, a net 547,544 shares.
Matt Davidson has 57 Form 4 filings on record from December 2018 to October 2026, across 3 companies: President and CEO at Azora Therapeutics (AZR), 2026; Chief Development Officer at Adial Pharmaceuticals (ADIL), 2026; 10% Owner at Verrica Pharmaceuticals (VRCA), 2018–2019.
The 198 reported transactions were 185 open-market sales, 7 option or other derivative awards and 6 stock awards.
Counted by filing, the open-market trades come to no purchases and 55 sales worth about $6.0M.
The largest open-market sale was 33,521 shares of VRCA at an average $11.63 on July 2, 2019, about $390K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2019 | VRCA Verrica Pharmaceuticals Inc. | 10% Owner | Sell | 19,314 | $10.89 | $210,333.04 | -0.7% | |
| Aug 29, 2019 | VRCA Verrica Pharmaceuticals Inc. | 10% Owner | Sell | 2,688 | $10.16 | $27,301.32 | -0.1% | |
| Aug 9, 2019 | VRCA Verrica Pharmaceuticals Inc. | 10% Owner | Sell | 6,313 | $10.49 | $66,200.17 | -0.2% | |
| Aug 6, 2019 | VRCA Verrica Pharmaceuticals Inc. | 10% Owner | Sell | 6,250 | $10.54 | $65,855.73 | -0.2% | |
| Aug 1, 2019 | VRCA Verrica Pharmaceuticals Inc. | 10% Owner | Sell | 10,338 | $11.92 | $123,236.96 | -0.4% | |
| Jul 29, 2019 | VRCA Verrica Pharmaceuticals Inc. | 10% Owner | Sell | 12,058 | $11.40 | $137,480.77 | -0.5% | |
| Jul 24, 2019 | VRCA Verrica Pharmaceuticals Inc. | 10% Owner | Sell | 2,802 | $10.24 | $28,682.38 | -0.1% | |
| Jul 19, 2019 | VRCA Verrica Pharmaceuticals Inc. | 10% Owner | Sell | 10,800 | $10.33 | $111,578.00 | -0.4% | |
| Jul 16, 2019 | VRCA Verrica Pharmaceuticals Inc. | 10% Owner | Sell | 10,490 | $10.93 | $114,662.10 | -0.4% | |
| Jul 11, 2019 | VRCA Verrica Pharmaceuticals Inc. | 10% Owner | Sell | 13,212 | $11.58 | $152,955.21 | -0.5% |